Loading...
We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord
- Ticker
- ALERS.PA
- Price
- 24.00
- Stock movement up
- +- (0.00%)
- Company name
- Eurobio Scientific SA
- Exchange
- (PA ,
- Currency
- EUR )
- Sector
- Healthcare >Medical Devices
- Market cap
- 241.64M
- Ent value
- -
- Price/Sales
- 1.01
- Price/Book
- -
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- 68.75
- Forward P/E
- 21.24
- PEG
- -
- EPS growth
- 6.19%
- 1 year return
- -5.14%
- 3 year return
- -
- 5 year return
- -
- 10 year return
- -
Last updated: 2026-01-15
DIVIDENDS
ALERS.PA does not pay dividends or no data was received
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | 68.75 |
| Price to OCF | 15.58 |
| Price to FCF | 17.97 |
| Price to EBITDA | 7.41 |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 1.01 |
| Price to Book | - |
| EV to Sales | - |
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 10.07M |
| EPS (TTM) | - |
| FCF per share (TTM) | - |
Income statement
Loading...
Income statement data
| Revenue (TTM) | - |
| Gross profit (TTM) | - |
| Operating income (TTM) | - |
| Net income (TTM) | - |
| EPS (TTM) | - |
| EPS (1y forward) | 1.13 |
Margins
Loading...
Margins data
| Gross margin (TTM) | - |
| Operating margin (TTM) | - |
| Profit margin (TTM) | - |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 0.00 |
| Net receivables | 0.00 |
| Total current assets | 0.00 |
| Goodwill | 0.00 |
| Intangible assets | 0.00 |
| Property, plant and equipment | 0.00 |
| Total assets | 0.00 |
| Accounts payable | 0.00 |
| Short/Current long term debt | 0.00 |
| Total current liabilities | 0.00 |
| Total liabilities | 0.00 |
| Shareholder's equity | 0.00 |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | - |
| Capital expenditures (TTM) | - |
| Free cash flow (TTM) | - |
| Dividends paid (TTM) | - |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | - |
| Return on Assets | - |
| Return on Invested Capital | - |
| Cash Return on Invested Capital | - |
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 23.95 |
| Daily high | 24.00 |
| Daily low | 23.95 |
| Daily Volume | 1K |
| All-time high | 435.35 |
| 1y analyst estimate | 30.00 |
| Beta | 0.67 |
| EPS (TTM) | - |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| ALERS.PA | S&P500 | |
| Current price drop from All-time high | -94.49% | -0.42% |
| Highest price drop | -94.65% | -19.00% |
| Date of highest drop | 7 Apr 2025 | 8 Apr 2025 |
| Avg drop from high | -94.23% | -2.51% |
| Avg time to new high | - | 6 days |
| Max time to new high | 323 days | 89 days |
COMPANY DETAILS
Marketcap
241.64M
Marketcap category
Small-cap
Description
Eurobio Scientific Société anonyme engages in the design, development, and commercialization of in vitro diagnostics products in the areas of transplantation, immunology, infectious diseases, life-science, and oncology. It commercializes media for the transportation and preservation of cornea grafts, as well as a device to facilitate the corresponding surgery; AlloMap, for heart transplant monitoring; cell culture media, molecular biology reagents, and proprietary antibodies; TQS (Tetanus Quick Stick) for the evaluation of patients' immune status against tetanus; and EBX molecular biology range, which includes a range of tests for identifying various pathogens responsible for infectious diseases. The company also develops other diagnostic products using molecular biology. The company was formerly known as Diaxonhit and changed its name to Eurobio Scientific Société anonyme in June 2018. Eurobio Scientific Société anonyme was incorporated in 1997 and is headquartered in Les Ulis, France.
Employees
380
Investor relations
-
SEC filings
CEO
Country
France
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
REPLACEMENT OF A STATUTORY AUDITOR Paris, December 22, 2025 – 6:00 pm Eurobio Scientific (FR0013240934, ALERS), a leading French group in in vitro medical diagnostics and life sciences, announces the ...
December 22, 2025
WOIPPY, France, November 14, 2025--Regulatory News: ABL Diagnostics (Euronext Paris: ABLD), a French company specializing in advanced molecular diagnostics, announces the signing of an exclusive distr...
November 14, 2025
RESULTS FOR THE FIRST SEMESTER OF FISCAL YEAR 2025 Revenue up 10% to €80.7 million Proprietary products account for 36% of revenue42% of revenue generated outside France 2025 results impacted by the t...
September 24, 2025
Eurobio Scientific completes the acquisition of Life Science unit of Voden Medical Instruments Spa in Italy Paris, July 1st, 2025 Eurobio Scientific (FR0013240934, ALERS), (FR0013240934, ALERS, PEA-PM...
July 1, 2025
EB Development rises above 90% threshold Paris, May 19, 2024 – 7:00 pm - Eurobio Scientific (FR0013240934, ALERS, PEA-PME eligible), a leading French group in in vitro medical diagnostics and life sci...
May 19, 2025
2024 ANNUAL RESULTS Growth of core business and strategic execution Revenue up 19% to €154 million Organic growth at +9%Proprietary products account for a stable 31% of group revenueInternational acco...
April 28, 2025
Amidst escalating trade tensions and fluctuating consumer sentiment, the European market has experienced a turbulent period, with the pan-European STOXX Europe 600 Index ending 1.92% lower before rebo...
April 16, 2025
Amidst a backdrop of uncertainty in the European markets, with the pan-European STOXX Europe 600 Index recently declining by 1.23% due to concerns over U.S. trade tariffs and monetary policy, investor...
March 18, 2025
EUROBIO SCIENTIFIC INCREASES ITS FOOTPRINT IN ITALY Signing of the acquisition of Life Science unit of Voden Medical Instruments SpaCompletion of the acquisition of Quimark SRLDecision of supplier T2 ...
March 12, 2025